Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Sell
2,340
-164
-7% -$29.7K 0.18% 96
2026
Q1
$368K Buy
2,504
+143
+6% +$23.2K 0.23% 81
2025
Q4
$460K Sell
2,361
-444
-16% -$106K 0.28% 64
2025
Q3
$789K Buy
2,805
+38
+1% +$9.68K 0.49% 41
2025
Q2
$605K Sell
2,767
-112
-4% -$18.1K 0.42% 47
2025
Q1
$403K Sell
2,879
-375
-12% -$61.1K 0.32% 68
2024
Q4
$542K Buy
3,254
+120
+4% +$21.3K 0.39% 58
2024
Q3
$534K Buy
3,134
+22
+0.7% +$3.19K 0.39% 57
2024
Q2
$439K Buy
3,112
+807
+35% +$100K 0.36% 64
2024
Q1
$289K Buy
+2,305
New +$264K 0.26% 90

Other funds holding ORCL

M3 Advisory Group's ORCL Position: Q2 2026 in Review

M3 Advisory Group reduced its Oracle (ORCL) stake by 6.5% in Q2 2026, selling an estimated $29.7K and leaving 2,340 shares worth $343K. The position accounts for 0.18% of the portfolio, ranked #96.

M3 Advisory Group first reported a position in ORCL in Q1 2024 and has held it in 10 quarters since. The position peaked at $789K in Q3 2025. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • M3 Advisory Group held 2,340 shares of Oracle worth $343K as of Q2 2026.
  • M3 Advisory Group sold 164 Oracle shares in Q2 2026, an estimated $29.7K.
  • Oracle made up 0.18% of M3 Advisory Group's portfolio in Q2 2026, its #96 holding.
  • M3 Advisory Group first reported a position in Oracle in Q1 2024 and has held it in 10 quarters since.
  • M3 Advisory Group's Oracle position peaked at $789K in Q3 2025.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on M3 Advisory Group's 13F filing for Q2 2026, filed 24 Jul 2026.